Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies. - Wikidata - awgldk - TriplyDB

Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.

Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.

http://www.wikidata.org/entity/Q40162770

about

Methylation detection oligonucleotide microarray analysis: a high-resolution method for detection of CpG island methylation.Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer.Involvement of members of the cadherin superfamily in cancer Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.Non-clustered protocadherin PCDH10 promoter hypermethylation is frequent in most histologic subtypes of mature lymphoid malignancies and occurs early in lymphomagenesis.Comparison of genomic DNA methylation pattern among septic and non-septic newborns - An epigenome wide association study.Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Age-related epigenetic drift in the pathogenesis of MDS and AML.Beyond E-cadherin: roles of other cadherin superfamily members in cancer.Meta-analysis of possible role of cadherin gene methylation in evolution and prognosis of hepatocellular carcinoma with a PRISMA guideline Regulation of Wnt signaling by protocadherins.Protocadherin γ A3 is expressed in follicular lymphoma irrespective of BCL2 status and is associated with tumor cell growth.Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.Aberrant expression and functions of protocadherins in human malignant tumors.Promoter methylation-mediated inactivation of PCDH10 in acute lymphoblastic leukemia contributes to chemotherapy resistance.Epigenetic inactivation of PCDH10 in human prostate cancer cell lines.Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer.Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma.Clinical and prognostic significance of protocadherin-10 (PCDH10) promoter methylation in bladder cancer.

P2860

Q30488766-86DE5737-E796-4AB9-8CC9-47C221B9CEB5 Q33630876-83E3FE1F-A41E-46CE-9EFF-E5A3BF76BADE Q33899441-60EAA0DE-1D56-4551-9F71-11A3D4FCA4D3 Q34318280-7849B767-217D-4F54-89D5-75FB5215B59C Q34568861-8661AFCF-909E-41BF-8F6D-F48695BB38B6 Q34891159-9F363C97-7903-496B-8E2A-7C5062B893C3 Q34912713-822F9907-E284-4157-AFDE-69E2EBB5663C Q35950873-62625431-4BB9-416C-BE93-B3092177518E Q36197642-C42056C0-C86A-4959-B7A7-BEFC0777AE9D Q37004635-C3751DD2-D569-43B6-8089-4535FE534E46 Q37683456-CAAF41CD-78FD-4633-ADB5-93FB6E799316 Q38179961-C82A8A5F-E959-4F68-A801-7B379ABC3917 Q38288318-0A4F5E3F-4D99-4FAE-B685-2FC32CFF23CF Q38642725-E1328DEC-187B-4933-8CE8-834F86313A46 Q38737506-E85A9068-64A4-4E50-914C-587FC8472B6B Q38903947-535FE751-0A0A-4B03-A4AE-DD22F0D02C7D Q38905879-CECC641D-52E9-41C3-B046-5416094017AB Q39465369-66DEBC1E-D3CB-4772-8145-0F3CC3A1E259 Q39593973-F2A5D49D-B332-4E48-B499-F8696505CE87 Q44129766-94369340-24FD-42B8-8260-A57EEC9B7333 Q47160551-26BAFD36-1D62-48C4-9315-4C04D9D347A3 Q54275602-CAD58FFF-4875-4D7B-B73A-9111D6DA3823

P2860

Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.

http://www.wikidata.org/entity/Q40162770

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Frequent epigenetic silencing ...... ple haematologic malignancies.

@en

type

label

Frequent epigenetic silencing ...... ple haematologic malignancies.

@en

prefLabel

Frequent epigenetic silencing ...... ple haematologic malignancies.

@en

P1433

Q40162770-E3AEE3D0-3E79-44A4-9E7E-288598CB51BB

P1476

Q40162770-3DDAAB3F-4F06-4EE5-A041-2C1848DC08D3

P2093

Q40162770-0475AC0D-99E2-4421-96F9-83331B62F9C7

Q40162770-24B227FA-C561-4168-BA7F-98F11FEAC400

Q40162770-2EEFEBC7-6AE7-4D49-9DDC-7BAC79A46CEC

Q40162770-37582784-BEA1-4579-9407-40E640E23B19

Q40162770-3C23DFED-B1C8-459E-B8EB-30890AD604DE

Q40162770-4B9BCE87-C660-4C2C-8FD1-9B32B66A84BC

Q40162770-4D6C982C-5D29-4D12-B47C-32AE5D796024

Q40162770-679EEC7D-94E7-4162-A0CE-05CE65647677

Q40162770-724FD54D-EEF7-4C19-A948-AA1E832F04DE

Q40162770-7D9D4C17-722F-4AC3-910E-E16F065E9499

P2860

Q40162770-16715A03-2F34-4E9F-AF43-720044A342FF

Q40162770-431CFAF2-6594-44E0-BE1F-0117A7828284

Q40162770-742AAEDE-4C8C-4AF9-AE71-C5495214EEB1

Q40162770-91404FB1-F20C-4FD0-BB84-55E60B3B1136

Q40162770-9FA0AAB4-25C9-4D01-8871-1AADCA5D54C0

Q40162770-B88874DF-2CDF-40BD-BB5B-C4807820CAD7

Q40162770-BC6A69F5-F2B3-42C0-B3BA-22CAE1796091

Q40162770-F86EC1DF-89A4-473A-AE19-13C9297023CC

Q40162770-FC0C8DE8-F13E-43AE-A105-7EA9004FEA3D

Q40162770-FDA81317-B9BB-4843-B181-1BC959870176

P304

Q40162770-3C125502-2017-4530-8A47-03D55245F64E

P31

Q40162770-60892623-53FF-4937-BDCA-32DC0B872C3B

P356

Q40162770-851E1F5F-6821-4A77-BDEE-366A33CD902B

P407

Q40162770-C6E3A46F-D9E1-4EC4-B527-F05503BE250A

P433

Q40162770-536CB1A7-CB8C-4D2A-A3D1-B4B6A7AB2499

P478

Q40162770-77D946DC-56F2-48D9-9CCE-AD8548A170F1

P577

Q40162770-28E42844-4EE7-4073-BCC0-AA0CFB2F8A79

P5875

Q40162770-E5FEFE28-F8AD-4C76-B6FA-A77CD1BF9B6E

P698

Q40162770-1780D13A-AD6D-4435-8327-ACDC4BEA4824

P356

J.1365-2141.2007.06512.X

P1433

British Journal of Haematology

P1476

Frequent epigenetic silencing ...... ple haematologic malignancies.

@en

P2093

Anthony T C Chan

http://www.w3.org/2001/XMLSchema#string

Chai Yen Lim

http://www.w3.org/2001/XMLSchema#string

David Y Mason

http://www.w3.org/2001/XMLSchema#string

Gopesh Srivastava

http://www.w3.org/2001/XMLSchema#string

Hongyu Li

http://www.w3.org/2001/XMLSchema#string

Hwee Koon Goh

http://www.w3.org/2001/XMLSchema#string

Jianming Ying

http://www.w3.org/2001/XMLSchema#string

Paul G Murray

http://www.w3.org/2001/XMLSchema#string

Qian Tao

http://www.w3.org/2001/XMLSchema#string

Richard F Ambinder

http://www.w3.org/2001/XMLSchema#string

P2860

Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation

Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia.

Epigenetic targets in hematopoietic malignancies.

Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.

Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers.

The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.

Frequent epigenetic inactivation of the RASSF1A tumor suppressor gene in Hodgkin's lymphoma.

Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.

P304

829-832

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2007.06512.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

136

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6466049

http://www.w3.org/2001/XMLSchema#string

P698

17341268

http://www.w3.org/2001/XMLSchema#string